
BlackRock Science (BSTZ) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
1.6B
Total Liabilities
62.1M
Shareholders Equity
1.5B
Debt to Equity
0.04
Cash Flow Metrics
Revenue & Profitability Trend
BlackRock Science Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 274.2M | 282.2M | -1.3B | 250.7M | 1.5B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 748.9K | 1.3M | 1.4M | 1.8M | 1.5M |
Other Operating Expenses | 1.1M | 909.1K | 409.9K | 326.3K | 374.9K |
Total Operating Expenses | 1.9M | 2.2M | 1.8M | 2.2M | 1.9M |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 272.3M | 280.0M | -1.3B | 248.5M | 1.5B |
Income Tax | - | - | - | - | - |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 272.3M | 280.0M | -1.3B | 248.5M | 1.5B |
Net Margin % | 99.3% | 99.2% | 0.0% | 99.1% | 99.9% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $7.86 | $3.72 | $-16.99 | $3.18 | $19.02 |
EPS (Diluted) | $7.86 | $3.72 | $-16.99 | $3.18 | $19.02 |
Basic Shares Outstanding | 72314687 | 75258409 | 78637947 | 78160293 | 78075711 |
Diluted Shares Outstanding | 72314687 | 75258409 | 78637947 | 78160293 | 78075711 |
Income Statement Trend
BlackRock Science Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 12.7K | 0 | 1.4M | 209.8K | 35.9K |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 1.7B | 1.7B | 1.5B | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | 984.9K | 4.5M | 0 | 1.8M |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 152.1K | 347.4K | - | - | - |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 25.1M | 27.9M | 21.0M | - | - |
Equity | |||||
Common Stock | 1.0B | 1.2B | 1.4B | 1.5B | 1.5B |
Retained Earnings | 644.3M | 425.3M | 152.3M | 1.5B | 1.5B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.7B | 1.6B | 1.5B | 3.0B | 3.0B |
Key Metrics | |||||
Total Debt | 152.1K | 347.4K | 0 | 0 | 0 |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
BlackRock Science Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 277.5M | 280.0M | -1.3B | 248.5M | 1.5B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 4.8M | 3.6M | -2.7M | 2.1M | -66.8M |
Operating Cash Flow | 282.3M | 283.5M | -1.3B | 250.6M | 1.4B |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Activities | |||||
Share Repurchases | -82.2M | -36.3M | -5.4M | - | - |
Dividends Paid | -151.5M | -142.8M | -178.6M | -225.1M | -97.0M |
Debt Issuance | - | - | 0 | 0 | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -233.8M | -179.1M | -184.0M | -225.1M | -97.0M |
Free Cash Flow | 231.7M | 173.4M | 183.8M | 213.9M | 107.2M |
Net Change in Cash | 48.5M | 104.5M | -1.5B | 25.5M | 1.3B |
Cash Flow Trend
BlackRock Science Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
3.65
Price to Sales
5.70
Profitability Ratios
Profit Margin
0.00%
Operating Margin
0.00%
Return on Equity
16.27%
Return on Assets
16.03%
Financial Health
Debt to Equity
0.00
Per Share Data
EPS (TTM)
$6.22
Revenue per Share
$3.79
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
bstz | 1.6B | 3.65 | - | 16.27% | 0.00% | 0.00 |
BlackRock | 179.7B | 28.09 | 3.66 | 13.92% | 29.69% | 28.51 |
Brookfield | 103.4B | 232.59 | 2.46 | 0.95% | 0.73% | 156.81 |
SRH Total Return | 1.8B | 5.48 | 0.84 | 16.36% | 928.40% | 10.77 |
Acadian Asset | 1.8B | 19.43 | 179.92 | 301.03% | 16.65% | 412.31 |
BlackRock Capital | 1.6B | 9.90 | - | 11.30% | 0.00% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.